Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

240 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fatal coxsackievirus B4 infection in a neonate.
Porres ER, Werthammer J, Moss N, Bernstein JM, Belshe RB. Porres ER, et al. Among authors: belshe rb. South Med J. 1985 Oct;78(10):1254-6. doi: 10.1097/00007611-198510000-00028. South Med J. 1985. PMID: 2996154
Impact of removing gentamicin from an antibiotic restriction program.
Gorse GJ, Belshe RB. Gorse GJ, et al. Among authors: belshe rb. South Med J. 1985 Oct;78(10):1194-7. doi: 10.1097/00007611-198510000-00013. South Med J. 1985. PMID: 4049037
HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).
Schulte JM, Bellamy AR, Hook EW 3rd, Bernstein DI, Levin MJ, Leone PA, Sokol-Anderson ML, Ewell MG, Wolff PA, Heineman TC, Belshe RB. Schulte JM, et al. Among authors: belshe rb. South Med J. 2014 Feb;107(2):79-84. doi: 10.1097/SMJ.0000000000000062. South Med J. 2014. PMID: 24926671
Seroepidemiology of astrovirus MLB1.
Holtz LR, Bauer IK, Jiang H, Belshe R, Freiden P, Schultz-Cherry SL, Wang D. Holtz LR, et al. Among authors: belshe r. Clin Vaccine Immunol. 2014 Jun;21(6):908-11. doi: 10.1128/CVI.00100-14. Epub 2014 Apr 30. Clin Vaccine Immunol. 2014. PMID: 24789796 Free PMC article.
Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial.
Gorfinkel IS, Aoki F, McNeil S, Dionne M, Shafran SD, Zickler P, Halperin S, Langley J, Bellamy A, Schulte J, Heineman T, Belshe R. Gorfinkel IS, et al. Among authors: belshe r. Int J STD AIDS. 2013 May;24(5):345-9. doi: 10.1177/0956462412472822. Int J STD AIDS. 2013. PMID: 23970700 Clinical Trial.
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.
Belshe RB, Frey SE, Graham I, Mulligan MJ, Edupuganti S, Jackson LA, Wald A, Poland G, Jacobson R, Keyserling HL, Spearman P, Hill H, Wolff M; National Institute of Allergy and Infectious Diseases-Funded Vaccine and Treatment Evaluation Units. Belshe RB, et al. J Infect Dis. 2011 Mar 1;203(5):666-73. doi: 10.1093/infdis/jiq093. Epub 2011 Jan 31. J Infect Dis. 2011. PMID: 21282194 Free PMC article. Clinical Trial.
Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.
Frey SE, Bernstein DI, Gerber MA, Keyserling HL, Munoz FM, Winokur PL, Turley CB, Rupp RE, Hill H, Wolff M, Noah DL, Ross AC, Cress G, Belshe RB. Frey SE, et al. Among authors: belshe rb. J Infect Dis. 2012 Sep 15;206(6):828-37. doi: 10.1093/infdis/jis445. Epub 2012 Jul 16. J Infect Dis. 2012. PMID: 22802432 Free PMC article. Clinical Trial.
A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066).
Frey SE, Lottenbach K, Graham I, Anderson E, Bajwa K, May RC, Mizel SB, Graff A, Belshe RB. Frey SE, et al. Among authors: belshe rb. Vaccine. 2017 Dec 4;35(48 Pt B):6759-6765. doi: 10.1016/j.vaccine.2017.09.070. Epub 2017 Oct 14. Vaccine. 2017. PMID: 29037578 Clinical Trial.
Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults.
Hoft DF, Lottenbach KR, Blazevic A, Turan A, Blevins TP, Pacatte TP, Yu Y, Mitchell MC, Hoft SG, Belshe RB. Hoft DF, et al. Among authors: belshe rb. Clin Vaccine Immunol. 2017 Jan 5;24(1):e00414-16. doi: 10.1128/CVI.00414-16. Print 2017 Jan. Clin Vaccine Immunol. 2017. PMID: 27847366 Free PMC article.
240 results
Jump to page